Dr. Edward M. Soffen, MD

Dr. Soffen practices at Procure Proton Therapy Center in Somerset, New Jersey.

Dr. Soffen's NPI, 1841200706, was assigned on August 9, 2006. Dr. Soffen graduated from Temple University School of Medicine in 1986. Dr. Soffen holds New Jersey license 25MA05629700.

Dr. Soffen's primary practice is Procure Proton Therapy Center, at 103 Cedar Grove Ln, Somerset, NJ 08873 in Somerset County. The practice phone is (732) 357-2600.

Dr. Soffen's primary practice is Procure Proton Therapy Center in Somerset, New Jersey. Dr. Soffen is also affiliated with Atlantic Health CentraState Medical Center. The medical group on file is Astera Cancer Care. Dmand AI also links Dr. Soffen to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soffen practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Soffen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Soffen's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 3,952 Medicare services from Dr. Soffen across 34 procedure codes in 2024, for 775 Medicare patients. Medicare paid $887,364 for them.

CMS counts 775 Medicare patients who saw Dr. Soffen in 2024. The largest group is 75 to 84, with 355 patients. 75% of them have cancer, and 75% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Soffen's median patient age at 72, with 39% women.

In 2024, Dr. Soffen wrote 359 Medicare Part D claims for 188 patients. 94% of them were for generic drugs. CMS names the drug for 226 of them, across 5 drugs with 11 or more claims each, at $2,036 in total drug cost. In 2023, CMS named 171 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Soffen for performance year 2024, reported individually. Dr. Soffen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Soffen as offering telehealth.

Dmand AI links 11 papers to Dr. Soffen, published from 2015 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Radiotherapy, Intensity-Modulated and Rectum. Dr. Soffen has published most often in Int J Radiat Oncol Biol Phys. Dr. Soffen's most frequent co-authors are Hiram Alberto Gay, MD, Jeff Michael Michalski, MD and Richard S. Hudes, MD.

Dmand AI links Dr. Soffen to 1 clinical trial.

CMS Open Payments shows 156 general payments to Dr. Soffen from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Augmenix, Inc. paid the most, $55,862.

Dr. Soffen graduated from Temple University School of Medicine in 1986.